Doyle Mittie insider trades
Doyle Mittie has filed 22 Form 4s with the SEC that we hold, for Avalo Therapeutics, Inc. (AVTX) (Chief Medical Officer), Cullinan Therapeutics, Inc. (CGEM) (Director) and DICE (Director). Across all of them we count 0 purchases worth $0 and 17 sales worth $3.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 17 sales ($3.0M). The largest single trade was a sale of 44,944 shares of Avalo Therapeutics, Inc. worth $952.8K, dated 2026-05-06. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-04-01 and the latest 2026-09-01.
Avalo Therapeutics, Inc. (AVTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-16 | S, sale reported on Form 4 | 25,492 | $411.7K | 2026-03-18 |
| 2026-04-01 | S, sale reported on Form 4 | 679 | $10.9K | 2026-04-03 |
| 2026-04-06 | S, sale reported on Form 4 | 3,970 | $71.5K | 2026-04-08 |
| 2026-05-05 | S, sale reported on Form 4 | 1,679 | $26.9K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 19,015 | $426.1K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 44,944 | $952.8K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 5,000 | $98.2K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 27,538 | $496.5K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 10,058 | $230.1K | 2026-05-07 |
| 2026-05-15 | S, sale reported on Form 4 | 3,000 | $56.3K | 2026-05-19 |
| 2026-05-28 | S, sale reported on Form 4 | 679 | $10.9K | 2026-06-01 |
| 2026-06-23 | S, sale reported on Form 4 | 1,450 | $26.1K | 2026-06-25 |
| 2026-06-30 | S, sale reported on Form 4 | 4,654 | $93.1K | 2026-07-02 |
| 2026-07-27 | S, sale reported on Form 4 | 1,000 | $20.0K | 2026-07-29 |
| 2026-08-10 | S, sale reported on Form 4 | 679 | $13.6K | 2026-08-12 |
| 2026-08-17 | S, sale reported on Form 4 | 1,000 | $20.0K | 2026-08-19 |
| 2026-08-28 | S, sale reported on Form 4 | 679 | $13.6K | 2026-09-01 |
Cullinan Therapeutics, Inc. (CGEM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
DICE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1918845) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms